Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (23480)	7/24/1998 2:16:00 PM
From: Machaon	Read Replies (2) \| Respond to of 32384

Henry, sometimes you leave too much to interpretation, at least as far as it applies to me. Also, a lot of this science is way over my head! Is the implication that, since Accutane is a retinoid in pre-clinical trials, and LGND's retinoid drugs are way ahead of the competition, and close to possible approval, that these Accutane tests could relate to Targretin and Panretin? How do the properties of different retinoids compare? Could Accutane's effects against cancer be completely different than Ligand's? Thanks, Bob ps: By the way, there are "so called" LGND shareholders on this thread that are complaining because we are discussing the merits of Ligand's science. It reminds me of an old saying: God sure must've loved morons, because he made a lot of them! <g>